| Authors: |
Griffiths RR; Department of Psychiatry and Behavioral Sciences, Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Jesse R; Department of Psychiatry and Behavioral Sciences, Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Richards WA; Department of Psychiatry and Behavioral Sciences, Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Johnson MW; Sheppard Pratt, Center for Excellence in Psilocybin Research and Treatment, Baltimore, Maryland, USA., Sepeda ND; Department of Psychiatry and Behavioral Sciences, Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Center for Psychedelic Drug Research and Education, Ohio State University College of Social Work, Columbus, Ohio, USA., Bossis AP; NYU Langone Center for Psychedelic Medicine, Department of Psychiatry, New York University (NYU) Grossman School of Medicine, New York, New York, USA.; Department of Classics and Religious Studies, University of Ottawa, Ottawa, Canada., Ross S; NYU Langone Center for Psychedelic Medicine, Department of Psychiatry, New York University (NYU) Grossman School of Medicine, New York, New York, USA.; NYU Institute for Translational Neuroscience, New York, New York, USA. |
